by AdoloreJTC24 | Jan 17, 2023 | Press Releases
Mr. Rongen appointed as CEO and member of the Board bringing 30 years of executive leadership experience and expertise across a number of therapeutic areasBolstered expertise on Board of Directors with addition of Dr. Rogers who brings significant leadership and...
by AdoloreJTC24 | Nov 14, 2022 | Press Releases
Company to discuss its next generation, disease-modifying, non-opioid analgesic gene therapy in development for the treatment of chronic painDELRAY BEACH, FL / November 14, 2022 / Adolore BioTherapeutics, Inc. (“Adolore” or the “Company”), a...